Global Therapeutic Nuclear Medicines Market Research Report 2022(Status and Outlook)
Global Therapeutic Nuclear Medicines Market Research Report 2022(Status and Outlook)
Abstract
Report Overview
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope and Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 5 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
The Global Therapeutic Nuclear Medicines Market Size was estimated at USD 1415.56 million in 2021 and is projected to reach USD 4557.60 million by 2028, exhibiting a CAGR of 18.18% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Therapeutic Nuclear Medicines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Nuclear Medicines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Nuclear Medicines market in any manner.
Global Therapeutic Nuclear Medicines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Novartis AG
•Bayer
•China Isotope and Radiation
•Q BioMed
•Curium Pharmaceuticals
•Jubilant DraxImage
•Dongcheng
•Lantheus
•Acrotech Biopharma.
•Progenics Pharmaceuticals
•International Isotopes
Market Segmentation (by Type)
•Radium-223
•Lutetium-177
•Iodine-131
•Other
Market Segmentation (by Application)
•Thyroid
•Bone Metastasis
•Lymphoma
•Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Therapeutic Nuclear Medicines Market
• Overview of the regional outlook of the Therapeutic Nuclear Medicines Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Nuclear Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Content
TABLE OF CONTENTS
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Therapeutic Nuclear Medicines
1.2 Key Market Segments
1.2.1 Therapeutic Nuclear Medicines Segment by Type
1.2.2 Therapeutic Nuclear Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Therapeutic Nuclear Medicines Market Overview
2.1 Global Market Overview
2.1.1 Global Therapeutic Nuclear Medicines Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Therapeutic Nuclear Medicines Market Competitive Landscape
3.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2022)
3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2022)
3.3 Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Therapeutic Nuclear Medicines Sales Sites, Area Served, Product Type
3.6 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
3.6.1 Therapeutic Nuclear Medicines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Nuclear Medicines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Therapeutic Nuclear Medicines Industry Chain Analysis
4.1 Therapeutic Nuclear Medicines Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Therapeutic Nuclear Medicines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Therapeutic Nuclear Medicines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)
6.3 Global Therapeutic Nuclear Medicines Market Size Market Share by Type (2017-2022)
6.4 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
7 Therapeutic Nuclear Medicines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Nuclear Medicines Market Sales by Application (2017-2022)
7.3 Global Therapeutic Nuclear Medicines Market Size (M USD) by Application (2017-2022)
7.4 Global Therapeutic Nuclear Medicines Sales Growth Rate by Application (2017-2022)
8 Therapeutic Nuclear Medicines Market Segmentation by Region
8.1 Global Therapeutic Nuclear Medicines Sales by Region
8.1.1 Global Therapeutic Nuclear Medicines Sales by Region
8.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Nuclear Medicines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Nuclear Medicines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Nuclear Medicines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Novartis AG
9.1.1 Novartis AG Therapeutic Nuclear Medicines Basic Information
9.1.2 Novartis AG Therapeutic Nuclear Medicines Product Overview
9.1.3 Novartis AG Therapeutic Nuclear Medicines Product Market Performance
9.1.4 Novartis AG Business Overview
9.1.5 Novartis AG Therapeutic Nuclear Medicines SWOT Analysis
9.1.6 Novartis AG Recent Developments
9.2 Bayer
9.2.1 Bayer Therapeutic Nuclear Medicines Basic Information
9.2.2 Bayer Therapeutic Nuclear Medicines Product Overview
9.2.3 Bayer Therapeutic Nuclear Medicines Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Therapeutic Nuclear Medicines SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 China Isotope and Radiation
9.3.1 China Isotope and Radiation Therapeutic Nuclear Medicines Basic Information
9.3.2 China Isotope and Radiation Therapeutic Nuclear Medicines Product Overview
9.3.3 China Isotope and Radiation Therapeutic Nuclear Medicines Product Market Performance
9.3.4 China Isotope and Radiation Business Overview
9.3.5 China Isotope and Radiation Therapeutic Nuclear Medicines SWOT Analysis
9.3.6 China Isotope and Radiation Recent Developments
9.4 Q BioMed
9.4.1 Q BioMed Therapeutic Nuclear Medicines Basic Information
9.4.2 Q BioMed Therapeutic Nuclear Medicines Product Overview
9.4.3 Q BioMed Therapeutic Nuclear Medicines Product Market Performance
9.4.4 Q BioMed Business Overview
9.4.5 Q BioMed Therapeutic Nuclear Medicines SWOT Analysis
9.4.6 Q BioMed Recent Developments
9.5 Curium Pharmaceuticals
9.5.1 Curium Pharmaceuticals Therapeutic Nuclear Medicines Basic Information
9.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Overview
9.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Market Performance
9.5.4 Curium Pharmaceuticals Business Overview
9.5.5 Curium Pharmaceuticals Therapeutic Nuclear Medicines SWOT Analysis
9.5.6 Curium Pharmaceuticals Recent Developments
9.6 Jubilant DraxImage
9.6.1 Jubilant DraxImage Therapeutic Nuclear Medicines Basic Information
9.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Overview
9.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Product Market Performance
9.6.4 Jubilant DraxImage Business Overview
9.6.5 Jubilant DraxImage Recent Developments
9.7 Dongcheng
9.7.1 Dongcheng Therapeutic Nuclear Medicines Basic Information
9.7.2 Dongcheng Therapeutic Nuclear Medicines Product Overview
9.7.3 Dongcheng Therapeutic Nuclear Medicines Product Market Performance
9.7.4 Dongcheng Business Overview
9.7.5 Dongcheng Recent Developments
9.8 Lantheus
9.8.1 Lantheus Therapeutic Nuclear Medicines Basic Information
9.8.2 Lantheus Therapeutic Nuclear Medicines Product Overview
9.8.3 Lantheus Therapeutic Nuclear Medicines Product Market Performance
9.8.4 Lantheus Business Overview
9.8.5 Lantheus Recent Developments
9.9 Acrotech Biopharma.
9.9.1 Acrotech Biopharma. Therapeutic Nuclear Medicines Basic Information
9.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Overview
9.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Market Performance
9.9.4 Acrotech Biopharma. Business Overview
9.9.5 Acrotech Biopharma. Recent Developments
9.10 Progenics Pharmaceuticals
9.10.1 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Basic Information
9.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Overview
9.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Market Performance
9.10.4 Progenics Pharmaceuticals Business Overview
9.10.5 Progenics Pharmaceuticals Recent Developments
9.11 International Isotopes
9.11.1 International Isotopes Therapeutic Nuclear Medicines Basic Information
9.11.2 International Isotopes Therapeutic Nuclear Medicines Product Overview
9.11.3 International Isotopes Therapeutic Nuclear Medicines Product Market Performance
9.11.4 International Isotopes Business Overview
9.11.5 International Isotopes Recent Developments
10 Therapeutic Nuclear Medicines Market Forecast by Region
10.1 Global Therapeutic Nuclear Medicines Market Size Forecast
10.2 Global Therapeutic Nuclear Medicines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Nuclear Medicines Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Nuclear Medicines Market Size Forecast by Region
10.2.4 South America Therapeutic Nuclear Medicines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Nuclear Medicines by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Therapeutic Nuclear Medicines Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Type (2022-2028)
11.1.2 Global Therapeutic Nuclear Medicines Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Therapeutic Nuclear Medicines by Type (2022-2028)
11.2 Global Therapeutic Nuclear Medicines Market Forecast by Application (2022-2028)
11.2.1 Global Therapeutic Nuclear Medicines Sales (K Units) Forecast by Application
11.2.2 Global Therapeutic Nuclear Medicines Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope and Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 5 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
The Global Therapeutic Nuclear Medicines Market Size was estimated at USD 1415.56 million in 2021 and is projected to reach USD 4557.60 million by 2028, exhibiting a CAGR of 18.18% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Therapeutic Nuclear Medicines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Nuclear Medicines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Nuclear Medicines market in any manner.
Global Therapeutic Nuclear Medicines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Novartis AG
•Bayer
•China Isotope and Radiation
•Q BioMed
•Curium Pharmaceuticals
•Jubilant DraxImage
•Dongcheng
•Lantheus
•Acrotech Biopharma.
•Progenics Pharmaceuticals
•International Isotopes
Market Segmentation (by Type)
•Radium-223
•Lutetium-177
•Iodine-131
•Other
Market Segmentation (by Application)
•Thyroid
•Bone Metastasis
•Lymphoma
•Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Therapeutic Nuclear Medicines Market
• Overview of the regional outlook of the Therapeutic Nuclear Medicines Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Nuclear Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Therapeutic Nuclear Medicines
1.2 Key Market Segments
1.2.1 Therapeutic Nuclear Medicines Segment by Type
1.2.2 Therapeutic Nuclear Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Therapeutic Nuclear Medicines Market Overview
2.1 Global Market Overview
2.1.1 Global Therapeutic Nuclear Medicines Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Therapeutic Nuclear Medicines Market Competitive Landscape
3.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2022)
3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2022)
3.3 Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Therapeutic Nuclear Medicines Sales Sites, Area Served, Product Type
3.6 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
3.6.1 Therapeutic Nuclear Medicines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Nuclear Medicines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Therapeutic Nuclear Medicines Industry Chain Analysis
4.1 Therapeutic Nuclear Medicines Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Therapeutic Nuclear Medicines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Therapeutic Nuclear Medicines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)
6.3 Global Therapeutic Nuclear Medicines Market Size Market Share by Type (2017-2022)
6.4 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
7 Therapeutic Nuclear Medicines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Nuclear Medicines Market Sales by Application (2017-2022)
7.3 Global Therapeutic Nuclear Medicines Market Size (M USD) by Application (2017-2022)
7.4 Global Therapeutic Nuclear Medicines Sales Growth Rate by Application (2017-2022)
8 Therapeutic Nuclear Medicines Market Segmentation by Region
8.1 Global Therapeutic Nuclear Medicines Sales by Region
8.1.1 Global Therapeutic Nuclear Medicines Sales by Region
8.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Nuclear Medicines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Nuclear Medicines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Nuclear Medicines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Novartis AG
9.1.1 Novartis AG Therapeutic Nuclear Medicines Basic Information
9.1.2 Novartis AG Therapeutic Nuclear Medicines Product Overview
9.1.3 Novartis AG Therapeutic Nuclear Medicines Product Market Performance
9.1.4 Novartis AG Business Overview
9.1.5 Novartis AG Therapeutic Nuclear Medicines SWOT Analysis
9.1.6 Novartis AG Recent Developments
9.2 Bayer
9.2.1 Bayer Therapeutic Nuclear Medicines Basic Information
9.2.2 Bayer Therapeutic Nuclear Medicines Product Overview
9.2.3 Bayer Therapeutic Nuclear Medicines Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Therapeutic Nuclear Medicines SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 China Isotope and Radiation
9.3.1 China Isotope and Radiation Therapeutic Nuclear Medicines Basic Information
9.3.2 China Isotope and Radiation Therapeutic Nuclear Medicines Product Overview
9.3.3 China Isotope and Radiation Therapeutic Nuclear Medicines Product Market Performance
9.3.4 China Isotope and Radiation Business Overview
9.3.5 China Isotope and Radiation Therapeutic Nuclear Medicines SWOT Analysis
9.3.6 China Isotope and Radiation Recent Developments
9.4 Q BioMed
9.4.1 Q BioMed Therapeutic Nuclear Medicines Basic Information
9.4.2 Q BioMed Therapeutic Nuclear Medicines Product Overview
9.4.3 Q BioMed Therapeutic Nuclear Medicines Product Market Performance
9.4.4 Q BioMed Business Overview
9.4.5 Q BioMed Therapeutic Nuclear Medicines SWOT Analysis
9.4.6 Q BioMed Recent Developments
9.5 Curium Pharmaceuticals
9.5.1 Curium Pharmaceuticals Therapeutic Nuclear Medicines Basic Information
9.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Overview
9.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Market Performance
9.5.4 Curium Pharmaceuticals Business Overview
9.5.5 Curium Pharmaceuticals Therapeutic Nuclear Medicines SWOT Analysis
9.5.6 Curium Pharmaceuticals Recent Developments
9.6 Jubilant DraxImage
9.6.1 Jubilant DraxImage Therapeutic Nuclear Medicines Basic Information
9.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Overview
9.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Product Market Performance
9.6.4 Jubilant DraxImage Business Overview
9.6.5 Jubilant DraxImage Recent Developments
9.7 Dongcheng
9.7.1 Dongcheng Therapeutic Nuclear Medicines Basic Information
9.7.2 Dongcheng Therapeutic Nuclear Medicines Product Overview
9.7.3 Dongcheng Therapeutic Nuclear Medicines Product Market Performance
9.7.4 Dongcheng Business Overview
9.7.5 Dongcheng Recent Developments
9.8 Lantheus
9.8.1 Lantheus Therapeutic Nuclear Medicines Basic Information
9.8.2 Lantheus Therapeutic Nuclear Medicines Product Overview
9.8.3 Lantheus Therapeutic Nuclear Medicines Product Market Performance
9.8.4 Lantheus Business Overview
9.8.5 Lantheus Recent Developments
9.9 Acrotech Biopharma.
9.9.1 Acrotech Biopharma. Therapeutic Nuclear Medicines Basic Information
9.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Overview
9.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Market Performance
9.9.4 Acrotech Biopharma. Business Overview
9.9.5 Acrotech Biopharma. Recent Developments
9.10 Progenics Pharmaceuticals
9.10.1 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Basic Information
9.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Overview
9.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Market Performance
9.10.4 Progenics Pharmaceuticals Business Overview
9.10.5 Progenics Pharmaceuticals Recent Developments
9.11 International Isotopes
9.11.1 International Isotopes Therapeutic Nuclear Medicines Basic Information
9.11.2 International Isotopes Therapeutic Nuclear Medicines Product Overview
9.11.3 International Isotopes Therapeutic Nuclear Medicines Product Market Performance
9.11.4 International Isotopes Business Overview
9.11.5 International Isotopes Recent Developments
10 Therapeutic Nuclear Medicines Market Forecast by Region
10.1 Global Therapeutic Nuclear Medicines Market Size Forecast
10.2 Global Therapeutic Nuclear Medicines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Nuclear Medicines Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Nuclear Medicines Market Size Forecast by Region
10.2.4 South America Therapeutic Nuclear Medicines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Nuclear Medicines by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Therapeutic Nuclear Medicines Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Therapeutic Nuclear Medicines by Type (2022-2028)
11.1.2 Global Therapeutic Nuclear Medicines Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Therapeutic Nuclear Medicines by Type (2022-2028)
11.2 Global Therapeutic Nuclear Medicines Market Forecast by Application (2022-2028)
11.2.1 Global Therapeutic Nuclear Medicines Sales (K Units) Forecast by Application
11.2.2 Global Therapeutic Nuclear Medicines Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
Related Report
